We observed a significant reduction in IVUS-derived TAV and a higher proportion of patients achieving PAV regression with PCSK9is, while the pooled change in PAV itself did not reach statistical significance.
← all excerpts
Proprotein Convertase Subtilisin/Kexin Type 9 and Atherosclerotic Plaque Progression: A Systematic Review and Meta-Analysis of Intravascular Imaging Studies.
1
—
—